<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Addict Sci Clin Pract</journal-id><journal-id journal-id-type="iso-abbrev">Addict Sci Clin Pract</journal-id><journal-title-group><journal-title>Addiction Science &#x00026; Clinical Practice</journal-title></journal-title-group><issn pub-type="ppub">1940-0632</issn><issn pub-type="epub">1940-0640</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3766125</article-id><article-id pub-id-type="publisher-id">1940-0640-8-S1-A61</article-id><article-id pub-id-type="doi">10.1186/1940-0640-8-S1-A61</article-id><article-categories><subj-group subj-group-type="heading"><subject>Meeting Abstract</subject></subj-group></article-categories><title-group><article-title>Screening and brief intervention for drug use in primary care: the Assessing Screening Plus brief Intervention&#x02019;s Resulting Efficacy to stop drug use (ASPIRE) randomized trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Saitz</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>rsaitz@bu.edu</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Palfai</surname><given-names>Tibor P</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Cheng</surname><given-names>Debbie M</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I4">4</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Alford</surname><given-names>Daniel P</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Bernstein</surname><given-names>Judith A</given-names></name><xref ref-type="aff" rid="I5">5</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Lloyd-Travaglini</surname><given-names>Christine A</given-names></name><xref ref-type="aff" rid="I4">4</xref><xref ref-type="aff" rid="I6">6</xref></contrib><contrib contrib-type="author" id="A7"><name><surname>Meli</surname><given-names>Seville M</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A8"><name><surname>Chaisson</surname><given-names>Christine E</given-names></name><xref ref-type="aff" rid="I4">4</xref><xref ref-type="aff" rid="I6">6</xref></contrib><contrib contrib-type="author" id="A9"><name><surname>Samet</surname><given-names>Jeffrey H</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I5">5</xref></contrib></contrib-group><aff id="I1"><label>1</label>Clinical Addiction Research and Education (CARE) Unit, Section of General Internal Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA</aff><aff id="I2"><label>2</label>Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA</aff><aff id="I3"><label>3</label>Department of Psychology, Boston University College of Arts and Sciences, Boston, Massachusetts, USA</aff><aff id="I4"><label>4</label>Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA</aff><aff id="I5"><label>5</label>Department of Community Health Sciences, Boston University School of Public Health, Boston, Massachusetts, USA</aff><aff id="I6"><label>6</label>Data Coordinating Center, Boston University School of Public Health, Boston, Massachusetts, USA</aff><pub-date pub-type="ppub"><year>2013</year></pub-date><pub-date pub-type="epub"><day>4</day><month>9</month><year>2013</year></pub-date><volume>8</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">International Network on Brief Interventions for Alcohol and Other Drugs (INEBRIA) Meeting 2013</named-content><named-content content-type="supplement-sponsor">Publication charges for this supplement were funded by the Italian Agency for Health Services #2 "Isontina", Tuscan Region, Goriza, Italy and the Agency for Public Health, Catalonia, Spain.</named-content></supplement><fpage>A61</fpage><lpage>A61</lpage><permissions><copyright-statement>Copyright &#x000a9; 2013 Saitz et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Saitz et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.ascpjournal.org/content/8/S1/A61"/><conference><conf-date>18-20 September 2013</conf-date><conf-name>International Network on Brief Interventions for Alcohol and Other Drugs (INEBRIA) Meeting 2013</conf-name><conf-loc>Rome, Italy</conf-loc></conference></article-meta></front><body><sec><title>Background</title><p>The efficacy of universal screening and brief intervention (SBI) for drug use among primary care (PC) patients is unknown.</p></sec><sec sec-type="methods"><title>Methods</title><p>In this randomized trial (the Assessing Screening Plus brief Intervention&#x02019;s Resulting Efficacy to stop drug use (ASPIRE) study) we tested the efficacy of a brief negotiated interview (BNI), and an adaptation of motivational interviewing (AMI), compared to no BI. Primary care patient participants had Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) drug specific scores of &#x02265;4. Primary outcome at 6 months was number of days use of the drug of most concern (DOMC) in the past 30 days.</p></sec><sec sec-type="results"><title>Results</title><p>Of 528 subjects, DOMC was: marijuana 63%, opioid 17% (prescription opioid 11%), and cocaine 19%. ASSIST score was &#x02265;27 (consistent with dependence) for 18%, mean days DOMC use (of 30 days) was 14.4. At 6 months, 98% completed follow-up and mean days DOMC use was 14.0. Mean adjusted days use of the DOMC at 6 months (negative binomial regression) was 11.5 (no BI) vs. 11.2 (BNI) (incidence rate ratio (IRR) 0.97, 95% CI 0.77-1.22) and 12.1 (AMI) (IRR 1.05, 95% CI 0.84-1.32) (p=0.81 for both comparisons vs. no BI). There were also no significant effects in analyses stratified by DOMC or ASSIST score.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>In this trial, BNI and AMI did not have efficacy for decreasing drug use. If other trials yield consistent results, widespread implementation of drug screening and BI should be reconsidered, and research should focus on alternative ways to address drug use and consequences in primary care settings. Funding was provided by the US National Institutes of Health (National Institute on Drug Abuse and National Center for Advancing Translational Sciences).</p></sec></body></article>